Feature Channels: Autoimmune Diseases

Filters close
Newswise: cells-13-00077-ag.png?1703905384
Released: 28-Feb-2024 3:05 AM EST
Biochemists discover what affects the development of autoimmune diseases
Scientific Project Lomonosov

The biochemist of RUDN University and Institute of Biomedical Chemistry was the first to study how variants of the protein that controls T-lymphocytes affect the development of autoimmune diseases using the example of multiple sclerosis. This will help find new approaches to the treatment of autoimmune diseases.

Released: 23-Feb-2024 1:05 PM EST
Researchers identify new choice of therapy for rare autoimmune disease EGPA
McMaster University

An international team, including researchers from McMaster University and St. Joseph’s Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior to mepolizumab in the treatment of EGPA.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 1:05 AM EST
The immune system’s moonlighters
Cold Spring Harbor Laboratory

Our immune system is remarkably powerful. It quickly assembles teams of cells to eliminate threats inside our bodies.

Not for public release

This news release is embargoed until 19-Feb-2024 5:00 PM EST Released to reporters: 13-Feb-2024 2:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 19-Feb-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 13-Feb-2024 8:05 PM EST
Better diagnosis and treatment of cryptococcosis
University of Cologne

A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.

Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Released: 12-Feb-2024 10:05 AM EST
Encefalite: Especialista da Mayo Clinic explica por que o tratamento precoce é importante
Mayo Clinic

A Encefalite é uma doença que envolve a inflamação ou inchaço do cérebro. Isso pode acontecer devido a infecções ou problemas no sistema imunológico, e o tratamento precoce é importante.

Released: 12-Feb-2024 10:05 AM EST
التهاب الدماغ: يشرح خبير من مايو كلينك سبب أهمية العلاج المبكر
Mayo Clinic

التهاب الدماغ هو مرض ينطوي على التهاب أو تورم الدماغ. ويمكن أن يحدث بسبب التهابات أو مشكلات تصيب الجهاز المناعي، والعلاج المبكر لتلك الحالة مهم. يقول ساروش إيراني، بكالوريوس الطب والجراحة.، طبيب الأعصاب، وباحث في مايو كلينك في جاكسونفيل، فلوريدا أنه لهذا السبب من الضروري رفع مستوى الوعي.

Released: 12-Feb-2024 10:05 AM EST
Encefalitis: Experto de Mayo Clinic explica por qué es importante el tratamiento temprano
Mayo Clinic

La Encefalitis es una enfermedad que implica inflamación o hinchazón del cerebro. Esto puede suceder debido a infecciones o problemas con el sistema inmunológico, y el tratamiento temprano es importante.

Released: 8-Feb-2024 8:50 AM EST
Atlantic Health System Enrolls First U.S. Patient in Lupus Treatment Trial
Atlantic Health System

NJ-based Atlantic Health System is the first in the U.S. to enroll a patient in a study to examine the effectiveness of using Chimeric Antigen Receptor (CAR- T) cells in the treatment of the autoimmune disease lupus.

Released: 31-Jan-2024 12:05 PM EST
Autoimmune disease and pregnancy
Institute for Systems Biology

For many aspiring mothers with autoimmune disease, pregnancy can be daunting and full of unknowns.

Newswise: New biomarkers for active lupus nephritis discovered
Released: 22-Jan-2024 4:05 PM EST
New biomarkers for active lupus nephritis discovered
University of Houston

New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.

Newswise: Bioengineered approach shows promise in ulcerative colitis
Released: 16-Jan-2024 10:05 AM EST
Bioengineered approach shows promise in ulcerative colitis
UT Southwestern Medical Center

By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis.

Released: 11-Jan-2024 10:05 AM EST
CD4+ T cell patterns linked to autoimmune disorders
Osaka University

Researchers from Osaka University find characteristic changes in CD4+ T cell categories and gene programs associated with autoimmune disease.

Released: 8-Jan-2024 4:05 PM EST
UTHealth Houston study: EBV-specific T-cells play key role in development of multiple sclerosis
University of Texas Health Science Center at Houston

The body’s immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by UTHealth Houston.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: NUS researchers develop an innovative and flexible method to study immune cell capabilities
Released: 17-Dec-2023 9:05 PM EST
NUS researchers develop an innovative and flexible method to study immune cell capabilities
National University of Singapore (NUS)

Researchers from the National University of Singapore (NUS) devise a simple and innovative way to directly identify and sort the immune cells involved in cell-mediated cytotoxicity.

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.



close
2.07685